Answer
Nitisinone weakly inhibits OAT1 and OAT3 and increases furosemide exposure (AUC) 1.7-fold.
Sources for this answer
- Orfadin 4mg/ml Oral SuspensionSwedish Orphan Biovitrum Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 10Document updated
Sources checked